Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorGONCALVES, Ruben
dc.contributor.authorCASTAING, Nadege
dc.contributor.authorRICHEVAL, Camille
dc.contributor.authorDUCINT, Dominique
dc.contributor.authorTITIER, Karine
dc.contributor.authorMORVAN, Estelle
hal.structure.identifierChimie et Biologie des Membranes et des Nanoobjets [CBMN]
dc.contributor.authorGRELARD, Axelle
hal.structure.identifierChimie et Biologie des Membranes et des Nanoobjets [CBMN]
dc.contributor.authorLOQUET, Antoine
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOLIMARD, Mathieu
dc.date.accessioned2022-03-16T08:08:14Z
dc.date.available2022-03-16T08:08:14Z
dc.date.issued2022-04
dc.identifier.issn0379-0738en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/136471
dc.description.abstractEnMethoxpropamine (MXPr) is an arylcyclohexylamine dissociative drug with structural similarities with 3-MeO-PCE, ketamine and deschloroketamine. MXPr was identified for the first time in Europe in October 2019 in Denmark and is considered a new psychoactive substance. We undertook the molecular identification and characterization of MXPr in urine, hair and powder samples. We used a combination of several analytical methods: liquid-state nuclear magnetic resonance (NMR), infra-red spectroscopy (IR) and liquid chromatography high-resolution mass spectrometry (LC-HRMS). The second objective was to explore the metabolism of MXPr in silico and in vitro. To detect characteristic metabolites that prove MXPr consumption by urine analysis, pooled human liver microsome (pHLM) assays were performed and evaluated using liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QToF-MS). A software algorithm (Unifi®) was used to predict in silico biotransformations of MXPr. Three metabolites were identified in the in vitro studies including N-despropyl(nor)MXPr, O-desmethyl MXPr and dihydroMXPr. Most of these phase II metabolites were confirmed to be present in urine and hair samples collected from an MXPr consumer. This is the first report of the identification of MXPr in France with analytical findings. This study highlights the challenge of identifying new psychoactive substances (NPS) when they are missing from compound libraries and if a standard is not available. The use of various complementary analytical methods combined with HRMS offers a promising approach for the molecular characterization of NPS.
dc.language.isoENen_US
dc.subject.enMethoxpropamine
dc.subject.enMXPr
dc.subject.enHigh-resolution mass spectrometry
dc.subject.enLC-QTOF
dc.subject.enNMR
dc.subject.enIR spectroscopy
dc.subject.enIn vitro metabolism
dc.subject.enHair analysis
dc.title.enMethoxpropamine (MXPr) in powder, urine and hair samples: Analytical characterization and metabolite identification of a new threat
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.forsciint.2022.111215en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35151938en_US
bordeaux.journalForensic Science Internationalen_US
bordeaux.page111215en_US
bordeaux.volume333en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.institutionBordeaux INP
bordeaux.institutionCNRS
bordeaux.teamAHEAD_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03609919
hal.version1
hal.date.transferred2022-03-16T08:08:16Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Forensic%20Science%20International&rft.date=2022-04&rft.volume=333&rft.spage=111215&rft.epage=111215&rft.eissn=0379-0738&rft.issn=0379-0738&rft.au=GONCALVES,%20Ruben&CASTAING,%20Nadege&RICHEVAL,%20Camille&DUCINT,%20Dominique&TITIER,%20Karine&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée